67 related articles for article (PubMed ID: 16707926)
1. Identification and localization of heparin-binding region of snake venom VEGF and its blocking of VEGF-A165.
Tokunaga Y; Yamazaki Y; Morita T
Pathophysiol Haemost Thromb; 2005; 34(4-5):194-6. PubMed ID: 16707926
[TBL] [Abstract][Full Text] [Related]
2. Identification of the heparin-binding region of snake venom vascular endothelial growth factor (VEGF-F) and its blocking of VEGF-A165.
Yamazaki Y; Tokunaga Y; Takani K; Morita T
Biochemistry; 2005 Jun; 44(24):8858-64. PubMed ID: 15952792
[TBL] [Abstract][Full Text] [Related]
3. C-terminal heparin-binding peptide of snake venom VEGF specifically blocks VEGF-stimulated endothelial cell proliferation.
Yamazaki Y; Tokunaga Y; Takani K; Morita T
Pathophysiol Haemost Thromb; 2005; 34(4-5):197-9. PubMed ID: 16707927
[TBL] [Abstract][Full Text] [Related]
4. Localization of heparin- and neuropilin-1-recognition sites of viral VEGFs.
Tokunaga Y; Yamazaki Y; Morita T
Biochem Biophys Res Commun; 2006 Sep; 348(3):957-62. PubMed ID: 16899214
[TBL] [Abstract][Full Text] [Related]
5. Catalytically inactive phospholipase A2 homologue binds to vascular endothelial growth factor receptor-2 via a C-terminal loop region.
Fujisawa D; Yamazaki Y; Lomonte B; Morita T
Biochem J; 2008 May; 411(3):515-22. PubMed ID: 18251716
[TBL] [Abstract][Full Text] [Related]
6. Distinct architecture of lymphatic vessels induced by chimeric vascular endothelial growth factor-C/vascular endothelial growth factor heparin-binding domain fusion proteins.
Tammela T; He Y; Lyytikkä J; Jeltsch M; Markkanen J; Pajusola K; Ylä-Herttuala S; Alitalo K
Circ Res; 2007 May; 100(10):1468-75. PubMed ID: 17478733
[TBL] [Abstract][Full Text] [Related]
7. Specific distribution of VEGF-F in Viperinae snake venoms: isolation and characterization of a VGEF-F from the venom of Daboia russelli siamensis.
Tokunaga Y; Yamazaki Y; Morita T
Arch Biochem Biophys; 2005 Jul; 439(2):241-7. PubMed ID: 15992764
[TBL] [Abstract][Full Text] [Related]
8. Snake venom vascular endothelial growth factors (VEGFs) exhibit potent activity through their specific recognition of KDR (VEGF receptor 2).
Yamazaki Y; Takani K; Atoda H; Morita T
J Biol Chem; 2003 Dec; 278(52):51985-8. PubMed ID: 14600159
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a bicyclic peptide neuropilin-1 (NP-1) antagonist (EG3287) reveals importance of vascular endothelial growth factor exon 8 for NP-1 binding and role of NP-1 in KDR signaling.
Jia H; Bagherzadeh A; Hartzoulakis B; Jarvis A; Löhr M; Shaikh S; Aqil R; Cheng L; Tickner M; Esposito D; Harris R; Driscoll PC; Selwood DL; Zachary IC
J Biol Chem; 2006 May; 281(19):13493-13502. PubMed ID: 16513643
[TBL] [Abstract][Full Text] [Related]
10. Discovery of a novel vascular endothelial growth factor (VEGF) with no affinity to heparin in Gloydius tsushimaensis venom.
Nakamura H; Murakami T; Imamura T; Toriba M; Chijiwa T; Ohno M; Oda-Ueda N
Toxicon; 2014 Aug; 86():107-15. PubMed ID: 24857790
[TBL] [Abstract][Full Text] [Related]
11. Dynamics of a heparin-binding domain of VEGF(165) complexed with its inhibitor triamterene.
Jeong KW; Lee JY; Lee SA; Yang SP; Ko H; Kang DI; Chae CB; Kim Y
Biochemistry; 2011 Jun; 50(22):4843-54. PubMed ID: 21545128
[TBL] [Abstract][Full Text] [Related]
12. Crystal structures of novel vascular endothelial growth factors (VEGF) from snake venoms: insight into selective VEGF binding to kinase insert domain-containing receptor but not to fms-like tyrosine kinase-1.
Suto K; Yamazaki Y; Morita T; Mizuno H
J Biol Chem; 2005 Jan; 280(3):2126-31. PubMed ID: 15542594
[TBL] [Abstract][Full Text] [Related]
13. An engineered heparin-binding form of VEGF-E (hbVEGF-E). Biological effects in vitro and mobilizatiion of precursor cells.
Heil M; Mitnacht-Krauss R; Issbrücker K; van den Heuvel J; Dehio C; Schaper W; Clauss M; Weich HA
Angiogenesis; 2003; 6(3):201-11. PubMed ID: 15041796
[TBL] [Abstract][Full Text] [Related]
14. Solution structure of the heparin-binding domain of vascular endothelial growth factor.
Fairbrother WJ; Champe MA; Christinger HW; Keyt BA; Starovasnik MA
Structure; 1998 May; 6(5):637-48. PubMed ID: 9634701
[TBL] [Abstract][Full Text] [Related]
15. Snake venom Vascular Endothelial Growth Factors (VEGF-Fs) exclusively vary their structures and functions among species.
Yamazaki Y; Matsunaga Y; Tokunaga Y; Obayashi S; Saito M; Morita T
J Biol Chem; 2009 Apr; 284(15):9885-91. PubMed ID: 19208624
[TBL] [Abstract][Full Text] [Related]
16. Isolation and conformational analysis of fragment peptide corresponding to the heparin-binding site of hepatocyte growth factor.
Aoyama H; Naka D; Yoshiyama Y; Ishii T; Kondo J; Mitsuka M; Hayase T
Biochemistry; 1997 Aug; 36(33):10286-91. PubMed ID: 9254627
[TBL] [Abstract][Full Text] [Related]
17. Identification of heparin affin regulatory peptide domains with potential role on angiogenesis.
Polykratis A; Delbé J; Courty J; Papadimitriou E; Katsoris P
Int J Biochem Cell Biol; 2004 Oct; 36(10):1954-66. PubMed ID: 15203110
[TBL] [Abstract][Full Text] [Related]
18. Heparin affin regulatory peptide binds to vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis.
Héroult M; Bernard-Pierrot I; Delbé J; Hamma-Kourbali Y; Katsoris P; Barritault D; Papadimitriou E; Plouet J; Courty J
Oncogene; 2004 Mar; 23(9):1745-53. PubMed ID: 15001987
[TBL] [Abstract][Full Text] [Related]
19. Specific interaction of VEGF165 with beta-amyloid, and its protective effect on beta-amyloid-induced neurotoxicity.
Yang SP; Kwon BO; Gho YS; Chae CB
J Neurochem; 2005 Apr; 93(1):118-27. PubMed ID: 15773911
[TBL] [Abstract][Full Text] [Related]
20. The heparin-binding domain confers diverse functions of VEGF-A in development and disease: a structure-function study.
Krilleke D; Ng YS; Shima DT
Biochem Soc Trans; 2009 Dec; 37(Pt 6):1201-6. PubMed ID: 19909247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
